Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration. Borrelli E, Foti C, Ulla L, Porreca A, et al. Br J Ophthalmol 2025 Mar 23:bjo-2024-326152. doi: 10.1136/bjo-2024-326152.

Read + Share

Amedeo Smart

Independent Medical Education

Borrelli E, Foti C, Ulla L, Porreca A, et al. Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration. Br J Ophthalmol 2025 Mar 23:bjo-2024-326152. doi: 10.1136/bjo-2024-326152.
PMID: 40122580